Strategies To Counteract Side Effects Of New MS Therapies

Links shared publicly online about this topic.

1,749
total visits

Strategies To Counteract Side Effects Of New MS Therapies

The drawback of new immunotherapies in multiple sclerosis (MS) include severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis. Researchers recently employed plasmapheresis to eliminate the active pharmaceutical agent and thus clear the virus from the brain.

View full resource at sciencedaily.com

Tags: Immune, Infection, Brain, Encephalitis, Multiple Sclerosis, Pharma, Tysabri